Letters sent to healthcare professionals in May 2018

Letters were sent about azithromycin, Lynparza▼(Olaparib), Xgeva▼ (denosumab), Lymphoseek (tilmanocept), ReoPro (abciximab) and dolutegravir; you still have time to complete a quick survey to tell us your views on the way medicines safety issues are communicated.

In May 2018, letters were sent to healthcare professionals about:

You still have time to complete this 10-minute survey to tell us your views on the way medicines safety issues are communicated and how we might improve this to better support safe and effective use.

Published 22 June 2018